Vorstellung eines innovativen interdisziplinären, sektoren-übergreifenden und gestuften Behandlungskonzepts für Schmerzpatient*innen im Rahmen eines regionalen Selektivvertrages nach §140a SGB V

BACKGROUND: A graded therapeutic concept for the treatment of chronic pain patients in Germany is only available to a limited extent. Following the onset of coronavirus disease (COVID-19), care for these patients has become even worse. AIM: To develop and establish a cross-sector therapeutic concept for chronic pain patients as part of a selective contract. METHODS: Embedded in existing therapeutic procedures, we define seven clinical pathways (CPs) into which patients are directed, after an interdisciplinary assessment according to refined criteria. ORGANIZATION: In CP I, patients remain in standard therapy. In CP II, patients have the opportunity to participate in an additional inter-profession education program. In CP III, patients get a specialized outpatient treatment. CP IV is a partial inpatient treatment, where multiple inpatient attendance days are replaced by tele-medical treatment, via a rehabilitation app. CP V and VI are inpatient treatments over 8 and 15 days each. If patients need further psychotherapeutic support after an inpatient treatment, they can be treated by clinical psychotherapists for another six months in CP VII. EVALUATION: The evaluation takes place 3, 6 and 12 months after initial assessment and includes the German Pain Questionnaire with different psychometric tests.